American Green, Inc.
American Green, Inc. (ERBB) Stock Competitors & Peer Comparison
See (ERBB) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERBB | $0.00 | -20.00% | 444.2K | N/A | -$0.15 | N/A |
| IPSEY | $45.89 | +0.00% | 60.7B | 29.80 | $1.54 | +0.87% |
| TKPHF | $34.66 | +0.00% | 57.4B | 80.78 | $0.45 | +3.64% |
| MKGAF | $133.78 | +3.35% | 56.8B | 16.54 | $7.90 | +2.03% |
| MKKGY | $25.75 | -0.04% | 54.5B | 15.87 | $1.58 | +2.00% |
| HLNCF | $5.02 | -1.76% | 44.7B | 20.06 | $0.25 | +1.82% |
| SDZNY | $81.39 | -0.33% | 35.6B | 39.33 | $2.09 | +0.89% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOY | $11.00 | +2.33% | 18.5B | 17.00 | $0.64 | +1.88% |
| SGIOF | $21.48 | +9.09% | 18.3B | 16.78 | $1.28 | +2.06% |
Stock Comparison
ERBB vs IPSEY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, IPSEY has a market cap of 60.7B. Regarding current trading prices, ERBB is priced at $0.00, while IPSEY trades at $45.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 29.80. In terms of profitability, ERBB's ROE is +0.03%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, ERBB and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
ERBB vs TKPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TKPHF has a market cap of 57.4B. Regarding current trading prices, ERBB is priced at $0.00, while TKPHF trades at $34.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 80.78. In terms of profitability, ERBB's ROE is +0.03%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, ERBB and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
ERBB vs MKGAF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, MKGAF has a market cap of 56.8B. Regarding current trading prices, ERBB is priced at $0.00, while MKGAF trades at $133.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 16.54. In terms of profitability, ERBB's ROE is +0.03%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, ERBB is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check MKGAF's competition here
ERBB vs MKKGY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, MKKGY has a market cap of 54.5B. Regarding current trading prices, ERBB is priced at $0.00, while MKKGY trades at $25.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 15.87. In terms of profitability, ERBB's ROE is +0.03%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ERBB is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check MKKGY's competition here
ERBB vs HLNCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HLNCF has a market cap of 44.7B. Regarding current trading prices, ERBB is priced at $0.00, while HLNCF trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 20.06. In terms of profitability, ERBB's ROE is +0.03%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ERBB and HLNCF have similar daily volatility (0.00).Check HLNCF's competition here
ERBB vs SDZNY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SDZNY has a market cap of 35.6B. Regarding current trading prices, ERBB is priced at $0.00, while SDZNY trades at $81.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 39.33. In terms of profitability, ERBB's ROE is +0.03%, compared to SDZNY's ROE of +0.09%. Regarding short-term risk, ERBB is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check SDZNY's competition here
ERBB vs TEVJF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, ERBB is priced at $0.00, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, ERBB's ROE is +0.03%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, ERBB and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
ERBB vs SGIOY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SGIOY has a market cap of 18.5B. Regarding current trading prices, ERBB is priced at $0.00, while SGIOY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 17.00. In terms of profitability, ERBB's ROE is +0.03%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, ERBB is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check SGIOY's competition here
ERBB vs SGIOF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SGIOF has a market cap of 18.3B. Regarding current trading prices, ERBB is priced at $0.00, while SGIOF trades at $21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 16.78. In terms of profitability, ERBB's ROE is +0.03%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, ERBB and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
ERBB vs TAIPY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, ERBB is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, ERBB's ROE is +0.03%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, ERBB is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check TAIPY's competition here
ERBB vs ESALY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ERBB is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ERBB's ROE is +0.03%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ERBB is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check ESALY's competition here
ERBB vs BIOVF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, ERBB is priced at $0.00, while BIOVF trades at $41.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 275.47. In terms of profitability, ERBB's ROE is +0.03%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, ERBB and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
ERBB vs IPSEF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, ERBB is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, ERBB's ROE is +0.03%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, ERBB and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
ERBB vs ESAIY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ESAIY has a market cap of 8.7B. Regarding current trading prices, ERBB is priced at $0.00, while ESAIY trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 27.18. In terms of profitability, ERBB's ROE is +0.03%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, ERBB is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check ESAIY's competition here
ERBB vs ESALF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ESALF has a market cap of 8.6B. Regarding current trading prices, ERBB is priced at $0.00, while ESALF trades at $30.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 27.57. In terms of profitability, ERBB's ROE is +0.03%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, ERBB and ESALF have similar daily volatility (0.00).Check ESALF's competition here
ERBB vs SFOSF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SFOSF has a market cap of 6.2B. Regarding current trading prices, ERBB is priced at $0.00, while SFOSF trades at $2.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 12.94. In terms of profitability, ERBB's ROE is +0.03%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, ERBB and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
ERBB vs GZPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, ERBB is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, ERBB's ROE is +0.03%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, ERBB and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
ERBB vs HLUBF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, ERBB is priced at $0.00, while HLUBF trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 11.66. In terms of profitability, ERBB's ROE is +0.03%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ERBB and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
ERBB vs DNPUF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, DNPUF has a market cap of 5.7B. Regarding current trading prices, ERBB is priced at $0.00, while DNPUF trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 5.78. In terms of profitability, ERBB's ROE is +0.03%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, ERBB and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
ERBB vs SMDPY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SMDPY has a market cap of 5.2B. Regarding current trading prices, ERBB is priced at $0.00, while SMDPY trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 5.30. In terms of profitability, ERBB's ROE is +0.03%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, ERBB is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check SMDPY's competition here
ERBB vs LVZPF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, ERBB is priced at $0.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, ERBB's ROE is +0.03%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ERBB and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
ERBB vs HLBBF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, ERBB is priced at $0.00, while HLBBF trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 12.17. In terms of profitability, ERBB's ROE is +0.03%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ERBB and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
ERBB vs SGFEF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, ERBB is priced at $0.00, while SGFEF trades at $104.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, ERBB's ROE is +0.03%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, ERBB and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
ERBB vs APNHY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, APNHY has a market cap of 3.8B. Regarding current trading prices, ERBB is priced at $0.00, while APNHY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -57.40. In terms of profitability, ERBB's ROE is +0.03%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, ERBB and APNHY have similar daily volatility (0.00).Check APNHY's competition here
ERBB vs HKMPF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HKMPF has a market cap of 3.6B. Regarding current trading prices, ERBB is priced at $0.00, while HKMPF trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 9.03. In terms of profitability, ERBB's ROE is +0.03%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ERBB and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
ERBB vs HKMPY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HKMPY has a market cap of 3.5B. Regarding current trading prices, ERBB is priced at $0.00, while HKMPY trades at $32.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 8.88. In terms of profitability, ERBB's ROE is +0.03%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ERBB is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check HKMPY's competition here
ERBB vs ULIHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ULIHF has a market cap of 3.5B. Regarding current trading prices, ERBB is priced at $0.00, while ULIHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 7.29. In terms of profitability, ERBB's ROE is +0.03%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, ERBB and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
ERBB vs LBTSF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, ERBB is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, ERBB's ROE is +0.03%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, ERBB and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
ERBB vs APNHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, ERBB is priced at $0.00, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -48.33. In terms of profitability, ERBB's ROE is +0.03%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, ERBB and APNHF have similar daily volatility (0.00).Check APNHF's competition here
ERBB vs INVVY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ERBB is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ERBB's ROE is +0.03%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, ERBB and INVVY have similar daily volatility (0.00).Check INVVY's competition here
ERBB vs IZQVF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ERBB is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ERBB's ROE is +0.03%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, ERBB and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
ERBB vs NPNKF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, NPNKF has a market cap of 2.6B. Regarding current trading prices, ERBB is priced at $0.00, while NPNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 12.42. In terms of profitability, ERBB's ROE is +0.03%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, ERBB and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
ERBB vs HYPMY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HYPMY has a market cap of 2.5B. Regarding current trading prices, ERBB is priced at $0.00, while HYPMY trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 16.38. In terms of profitability, ERBB's ROE is +0.03%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ERBB is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check HYPMY's competition here
ERBB vs HMDCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, ERBB is priced at $0.00, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, ERBB's ROE is +0.03%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, ERBB and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
ERBB vs CHSYF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, ERBB is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, ERBB's ROE is +0.03%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, ERBB and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
ERBB vs DMPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ERBB is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, ERBB's ROE is +0.03%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, ERBB and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
ERBB vs TSMRF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, ERBB is priced at $0.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, ERBB's ROE is +0.03%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, ERBB and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
ERBB vs NPPNY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, NPPNY has a market cap of 2.1B. Regarding current trading prices, ERBB is priced at $0.00, while NPPNY trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 10.17. In terms of profitability, ERBB's ROE is +0.03%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, ERBB is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check NPPNY's competition here
ERBB vs HTSUF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, ERBB is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, ERBB's ROE is +0.03%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, ERBB and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
ERBB vs ARSUF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, ERBB is priced at $0.00, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 19.85. In terms of profitability, ERBB's ROE is +0.03%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, ERBB and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
ERBB vs DUTV Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, ERBB is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, ERBB's ROE is +0.03%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, ERBB is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check DUTV's competition here
ERBB vs CURLF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CURLF has a market cap of 1.8B. Regarding current trading prices, ERBB is priced at $0.00, while CURLF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -7.09. In terms of profitability, ERBB's ROE is +0.03%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, ERBB is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check CURLF's competition here
ERBB vs SHPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, ERBB is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, ERBB's ROE is +0.03%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, ERBB and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
ERBB vs MITPF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ERBB is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ERBB's ROE is +0.03%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, ERBB is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check MITPF's competition here
ERBB vs GTBIF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, ERBB is priced at $0.00, while GTBIF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 13.65. In terms of profitability, ERBB's ROE is +0.03%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, ERBB is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check GTBIF's competition here
ERBB vs KARBF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ERBB is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ERBB's ROE is +0.03%, compared to KARBF's ROE of N/A. Regarding short-term risk, ERBB and KARBF have similar daily volatility (0.00).Check KARBF's competition here
ERBB vs CHIZF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, ERBB is priced at $0.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, ERBB's ROE is +0.03%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, ERBB and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
ERBB vs CASBF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, ERBB is priced at $0.00, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -38.60. In terms of profitability, ERBB's ROE is +0.03%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, ERBB and CASBF have similar daily volatility (0.00).Check CASBF's competition here
ERBB vs SWGHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, ERBB is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, ERBB's ROE is +0.03%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, ERBB and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
ERBB vs KSPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, ERBB is priced at $0.00, while KSPHF trades at $26.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 13.95. In terms of profitability, ERBB's ROE is +0.03%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, ERBB and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
ERBB vs EVOTF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, EVOTF has a market cap of 1.3B. Regarding current trading prices, ERBB is priced at $0.00, while EVOTF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -6.53. In terms of profitability, ERBB's ROE is +0.03%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, ERBB and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
ERBB vs TWAPF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, ERBB is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, ERBB's ROE is +0.03%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, ERBB and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
ERBB vs TCNNF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, ERBB is priced at $0.00, while TCNNF trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -11.12. In terms of profitability, ERBB's ROE is +0.03%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, ERBB is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check TCNNF's competition here
ERBB vs LJUIF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, ERBB is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, ERBB's ROE is +0.03%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, ERBB and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
ERBB vs BIOGY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, ERBB is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, ERBB's ROE is +0.03%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, ERBB and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
ERBB vs SHEZF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, ERBB is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, ERBB's ROE is +0.03%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, ERBB and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
ERBB vs KKPCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, ERBB is priced at $0.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, ERBB's ROE is +0.03%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, ERBB and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
ERBB vs GNMLF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GNMLF has a market cap of 925.1M. Regarding current trading prices, ERBB is priced at $0.00, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 10.56. In terms of profitability, ERBB's ROE is +0.03%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, ERBB and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
ERBB vs CSWYF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, ERBB is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, ERBB's ROE is +0.03%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, ERBB and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
ERBB vs NIKA Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, ERBB is priced at $0.00, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, ERBB's ROE is +0.03%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, ERBB and NIKA have similar daily volatility (0.00).Check NIKA's competition here
ERBB vs TRXPF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, ERBB is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ERBB's ROE is +0.03%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ERBB and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
ERBB vs YIHCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, ERBB is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ERBB's ROE is +0.03%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, ERBB and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
ERBB vs AIHLF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, ERBB is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, ERBB's ROE is +0.03%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ERBB and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
ERBB vs TRSSF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ERBB is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ERBB's ROE is +0.03%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, ERBB is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check TRSSF's competition here
ERBB vs GLASF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GLASF has a market cap of 592.4M. Regarding current trading prices, ERBB is priced at $0.00, while GLASF trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -36.51. In terms of profitability, ERBB's ROE is +0.03%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, ERBB is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check GLASF's competition here
ERBB vs SWDCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SWDCF has a market cap of 575.4M. Regarding current trading prices, ERBB is priced at $0.00, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 90.00. In terms of profitability, ERBB's ROE is +0.03%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ERBB and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
ERBB vs PKBFF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, ERBB is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ERBB's ROE is +0.03%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ERBB and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
ERBB vs CCHWF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ERBB is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ERBB's ROE is +0.03%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, ERBB is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check CCHWF's competition here
ERBB vs BOIRF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, ERBB is priced at $0.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, ERBB's ROE is +0.03%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, ERBB and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
ERBB vs AGYTF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, ERBB is priced at $0.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, ERBB's ROE is +0.03%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, ERBB and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
ERBB vs KHTRF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, KHTRF has a market cap of 463.4M. Regarding current trading prices, ERBB is priced at $0.00, while KHTRF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is -153.80. In terms of profitability, ERBB's ROE is +0.03%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, ERBB and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
ERBB vs PEXXF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ERBB is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ERBB's ROE is +0.03%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ERBB and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
ERBB vs VRNOF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, VRNOF has a market cap of 459.5M. Regarding current trading prices, ERBB is priced at $0.00, while VRNOF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.28. In terms of profitability, ERBB's ROE is +0.03%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, ERBB is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check VRNOF's competition here
ERBB vs ELTP Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ELTP has a market cap of 430.8M. Regarding current trading prices, ERBB is priced at $0.00, while ELTP trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 10.00. In terms of profitability, ERBB's ROE is +0.03%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, ERBB is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check ELTP's competition here
ERBB vs HUMDF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, ERBB is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, ERBB's ROE is +0.03%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, ERBB and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
ERBB vs CRLBF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CRLBF has a market cap of 350.7M. Regarding current trading prices, ERBB is priced at $0.00, while CRLBF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -6.44. In terms of profitability, ERBB's ROE is +0.03%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, ERBB is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check CRLBF's competition here
ERBB vs CPHRF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CPHRF has a market cap of 278.3M. Regarding current trading prices, ERBB is priced at $0.00, while CPHRF trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 16.37. In terms of profitability, ERBB's ROE is +0.03%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, ERBB and CPHRF have similar daily volatility (0.00).Check CPHRF's competition here
ERBB vs BHCCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, ERBB is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ERBB's ROE is +0.03%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, ERBB and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
ERBB vs PLNHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ERBB is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ERBB's ROE is +0.03%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, ERBB is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check PLNHF's competition here
ERBB vs PHCUF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, ERBB is priced at $0.00, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -700.00. In terms of profitability, ERBB's ROE is +0.03%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, ERBB and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
ERBB vs SHIEF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, ERBB is priced at $0.00, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, ERBB's ROE is +0.03%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, ERBB and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
ERBB vs COPHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ERBB is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ERBB's ROE is +0.03%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ERBB is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check COPHF's competition here
ERBB vs LOVFF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, LOVFF has a market cap of 129.5M. Regarding current trading prices, ERBB is priced at $0.00, while LOVFF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 15.02. In terms of profitability, ERBB's ROE is +0.03%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, ERBB and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
ERBB vs BIOYF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, BIOYF has a market cap of 126.1M. Regarding current trading prices, ERBB is priced at $0.00, while BIOYF trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 20.36. In terms of profitability, ERBB's ROE is +0.03%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, ERBB is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check BIOYF's competition here
ERBB vs NWPN Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ERBB is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ERBB's ROE is +0.03%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ERBB is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check NWPN's competition here
ERBB vs CBWTF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CBWTF has a market cap of 117.6M. Regarding current trading prices, ERBB is priced at $0.00, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 2.91. In terms of profitability, ERBB's ROE is +0.03%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, ERBB is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check CBWTF's competition here
ERBB vs AAWH Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, AAWH has a market cap of 114.6M. Regarding current trading prices, ERBB is priced at $0.00, while AAWH trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -1.34. In terms of profitability, ERBB's ROE is +0.03%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, ERBB is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check AAWH's competition here
ERBB vs CWBHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CWBHF has a market cap of 111.6M. Regarding current trading prices, ERBB is priced at $0.00, while CWBHF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CWBHF's P/E ratio is -5.00. In terms of profitability, ERBB's ROE is +0.03%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, ERBB is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check CWBHF's competition here
ERBB vs LPCUF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, ERBB is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, ERBB's ROE is +0.03%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, ERBB and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
ERBB vs CNVCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ERBB is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ERBB's ROE is +0.03%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, ERBB and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
ERBB vs HLTRF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, HLTRF has a market cap of 107.6M. Regarding current trading prices, ERBB is priced at $0.00, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -7.64. In terms of profitability, ERBB's ROE is +0.03%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, ERBB and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
ERBB vs ORXOY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, ERBB is priced at $0.00, while ORXOY trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ORXOY's P/E ratio is -2.35. In terms of profitability, ERBB's ROE is +0.03%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, ERBB and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
ERBB vs JUSHF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, JUSHF has a market cap of 100.3M. Regarding current trading prices, ERBB is priced at $0.00, while JUSHF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.55. In terms of profitability, ERBB's ROE is +0.03%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, ERBB is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check JUSHF's competition here
ERBB vs ORXOF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ORXOF has a market cap of 100.1M. Regarding current trading prices, ERBB is priced at $0.00, while ORXOF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -2.30. In terms of profitability, ERBB's ROE is +0.03%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, ERBB and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
ERBB vs ABSCF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, ERBB is priced at $0.00, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, ERBB's ROE is +0.03%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, ERBB and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
ERBB vs GRUSF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GRUSF has a market cap of 82.4M. Regarding current trading prices, ERBB is priced at $0.00, while GRUSF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 11.00. In terms of profitability, ERBB's ROE is +0.03%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, ERBB is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check GRUSF's competition here
ERBB vs EOFBY Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, ERBB is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ERBB's ROE is +0.03%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, ERBB and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
ERBB vs MEDXF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, MEDXF has a market cap of 72M. Regarding current trading prices, ERBB is priced at $0.00, while MEDXF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -111.50. In terms of profitability, ERBB's ROE is +0.03%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, ERBB is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERBB.Check MEDXF's competition here
ERBB vs GDNSF Comparison March 2026
ERBB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERBB stands at 444.2K. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, ERBB is priced at $0.00, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERBB currently has a P/E ratio of N/A, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, ERBB's ROE is +0.03%, compared to GDNSF's ROE of -0.24%. Regarding short-term risk, ERBB and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here